NEORECORMON 4000UI / 0.3ml injection solution in pre-filled syringe medication leaflet

B03XA01 epoetin beta • Blood and blood forming organs | Other antianemic preparations

Epoetin beta is a medication used to treat anemia, especially in patients with chronic kidney failure or those undergoing dialysis. This medicine stimulates the production of red blood cells, helping to increase hemoglobin levels and reduce symptoms of fatigue. Epoetin beta is usually administered by subcutaneous or intravenous injection, as directed by the doctor.

Treatment with epoetin beta is closely monitored by the medical team, as the dose must be adjusted based on the body's response and hemoglobin levels. It is important for patients to strictly follow the doctor's recommendations and have regular blood tests to prevent complications.

Side effects may include high blood pressure, headaches, joint pain, or reactions at the injection site. In rare cases, severe allergic reactions or an increased risk of blood clots may occur.

Epoetin beta is an essential treatment for patients with severe anemia, but it requires constant medical supervision to ensure the therapy's effectiveness and safety. Open communication with the doctor is crucial for proper management of the treatment.

General data about NEORECORMON 4000UI / 0.3ml

Substance: epoetin beta

Date of last drug list: 01-06-2025

Commercial code: W64398002

Concentration: 4000UI / 0.3ml

Pharmaceutical form: injection solution in pre-filled syringe

Packing volume: 0,3ml

Product type: original

Price: 615.68 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ROCHE PHARMA AG - GERMANIA

Holder: ROCHE REGISTRATION GMBH - GERMANIA

Number: 31/2000/42

Shelf life: 2 years

Concentrations available for epoetin beta

10000UI/0.6ml, 10000UI/ml, 1000UI/0.3ml, 1000UI/ml, 20000UI/0.6ml, 20000UI/ml, 2000UI/0.3ml, 30000UI/0.6ml, 3000I/0.3ml, 4000UI/0.3ml, 50000UI/ml, 5000UI/0.3ml, 500UI/0.3ml, 60000UI/ml, 6000UI/0.3ml
PDF icon EMA leaflet
Published: 04/11/2008
Updated: 02/05/2025

Compensation lists for NEORECORMON 4000UI / 0.3ml EGIS

G10 (C1) - Leukemias, lymphomas and spinal cord aplasia, tumors

Price

Copayment

Patient

615.68 RON

615.68 RON

0.00 RON

G25 (C1) - Chronic renal failure

Price

Copayment

Patient

615.68 RON

615.68 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

615.68 RON

615.68 RON

0.00 RON

NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure

Price

Copayment

Patient

615.68 RON

615.68 RON

0.00 RON